Corcept Therapeutics
CORT
#2480
Rank
โ‚น494.94 B
Marketcap
โ‚น4,724
Share price
-0.30%
Change (1 day)
122.96%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2024 (TTM): โ‚น52.45 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น53.09 Billion. In 2023 the company made a revenue of โ‚น40.15 Billion an increase over the revenue in the year 2022 that were of โ‚น33.25 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น52.45 B30.61%
2023 โ‚น40.15 B20.76%
2022 โ‚น33.25 B22.08%
2021 โ‚น27.24 B5.25%
2020 โ‚น25.88 B18.41%
2019 โ‚น21.85 B24.41%
2018 โ‚น17.56 B72.82%
2017 โ‚น10.16 B83.94%
2016 โ‚น5.52 B65.37%
2015 โ‚น3.34 B98.58%
2014 โ‚น1.68 B163%
2013 โ‚น0.63 B253.38%
2012 โ‚น0.18 B
2011 N/A
2010 N/A-100%
2009 โ‚น1.39 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น7.408 T 13,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.007 T 7,446.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.218 T 7,845.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น3.451 T 6,401.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.700 T 8,752.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.277 T 9,840.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น23.46 B-55.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น20.98 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น232.54 B 337.96%๐Ÿ‡บ๐Ÿ‡ธ USA